AI-Designed Antibodies Work Inside Cells to Fight Dementia
Scientists used artificial intelligence to create tiny antibody fragments that can function inside human cells, targeting proteins that cause Alzheimer's, Parkinson's, and other brain diseases. This breakthrough overcomes a major limitation in medicine development and could lead to new treatments for conditions affecting over one million people in the UK alone.